Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer

文献类型: 外文期刊

第一作者: Ye, Jiahui

作者: Ye, Jiahui;Xie, Luoyijun;Zhang, Rongjun;Liu, Yulin;Li, Qingjiao;Yuan, Miaomiao;Mao, Longfei;Peng, Lizeng;Yang, Jianxue

作者机构:

关键词: theophylline; 1; 2; 3-triazole; apoptosis; NSCLC; antitumor

期刊名称:FRONTIERS IN PHARMACOLOGY ( 影响因子:5.811; 五年影响因子:6.006 )

ISSN:

年卷期: 2021 年 12 卷

页码:

收录情况: SCI

摘要: Chemotherapy is the most common clinical treatment for non-small cell lung cancer (NSCLC), but low efficiency and high toxicity of current chemotherapy drugs limit their clinical application. Therefore, it is urgent to develop hypotoxic and efficient chemotherapy drugs. Theophylline, a natural compound, is safe and easy to get, and it can be used as a modified scaffold structure and hold huge potential for developing safe and efficient antitumor drugs. Herein, we linked theophylline with different azide compounds to synthesize a new type of 1,2,3-triazole ring-containing theophylline derivatives. We found that some theophylline1,2,3-triazole compounds showed a good tumor-suppressive efficacy. Especially, derivative d17 showed strong antiproliferative activity against a variety of cancer cells in vitro, including H460, A549, A2780, LOVO, MB-231, MCF-7, OVCAR3, SW480, and PC-9. It is worth noting that the two NSCLC cell lines H460 H and A549 are sensitive to compound d17 particularly, with IC50 of 5.929 +/- 0.97 mu M and 6.76 +/- 0.25 mu M, respectively. Compound d17 can significantly induce cell apoptosis by increasing the ratio of apoptotic protein Bax/Bcl-2 by downregulating the expression of phosphorylated Akt protein, and it has little toxicity to normal hepatocyte cells LO2 at therapeutic concentrations. These data indicate that these theophylline acetic acid-1,2,3-triazole derivatives may be potential drug candidates for anti-NSCLC and are worthy of further study.

分类号:

  • 相关文献
作者其他论文 更多>>